Regeneron Pharmaceuticals, Inc. (REGN)
721.05
+18.78
(+2.67%)
USD |
NASDAQ |
May 06, 16:00
721.02
-0.03
(-0.00%)
Pre-Market: 08:27
Regeneron Pharmaceuticals Cash from Investing (Quarterly) : -428.90M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Eli Lilly & Co. | -3.916B |
| Merck & Co., Inc. | -10.21B |
| Pfizer Inc. | 785.00M |
| AbbVie, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.079B |
| Cash from Financing (Quarterly) | -802.20M |
| Free Cash Flow | 3.791B |
| Free Cash Flow Per Share (Quarterly) | 7.422 |
| Free Cash Flow to Equity (Quarterly) | 1.066B |
| Free Cash Flow to Firm (Quarterly) | 810.69M |
| Free Cash Flow Yield | 4.88% |